Artos at PDA's AI in Biopharmaceutical Development and Manufacturing Conference

Josh Kim speaks at the AI in Biopharmaceutical Development and Manufacturing Conference

We are excited to announce that Josh Kim, CEO and co-founder of Artos, will be a panelist at the upcoming AI in Biopharmaceutical Development and Manufacturing Conference. This 1.5-day event will provide insights on applications of AI in biopharma from industry experts, offering real life perspectives on implementation and tools to enhance your biopharma's operational capabilities.

The Cost of Document Management in Biopharma

Document creation and management represent significant operational costs for biopharmaceutical companies, particularly in regulatory affairs, where compliance and submission timelines are critical. Regulatory filing for pharmaceutical companies typically takes about eight to nine months, creating a significant gap between median industry timelines and best-in-class submission speeds. This delay directly impacts revenue, as accelerating submissions proportionately increases the prepatent loss period for which a drug is on the market. A McKinsey analysis estimates that every month of acceleration in the submission process translates into a net present value (NPV) gain of $25 million to $40 million, while each day of acceleration creates approximately $1 million in value. These estimates are conservative, as they do not account for competitive advantages gained by launching a product earlier than competitors.

AI for regulatory affairs

Implementing AI for regulatory affairs can streamline workflows, improve accuracy, and reduce manual effort, ultimately lowering costs and significantly accelerating submission timelines. Notably, automating Investigational New Drug (IND) submissions can reduce the time and resources needed to compile, review, and submit regulatory documents, expediting drug development and approvals. AI driven workflows can improve multiple parts of the process:

• Reduce time to generate first drafts

• Less errors and easier QC process

• Drive cost efficiencies immediately

Meet us in Vegas

We’re excited to meet industry leaders, exchange insights, and explore how AI agents can revolutionize regulatory submissions.

📅 Want to schedule a time to meet? Reach out to Josh (josh(at)artosai.com), or connect with us at the event.

See you in Vegas, March 20-21! 🚀